BCAB
Price
$0.52
Change
+$0.01 (+1.96%)
Updated
Jun 3, 04:06 PM (EDT)
Capitalization
29.79M
65 days until earnings call
HOOK
Price
$1.59
Change
+$0.02 (+1.27%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
19.14M
Interact to see
Advertisement

BCAB vs HOOK

Header iconBCAB vs HOOK Comparison
Open Charts BCAB vs HOOKBanner chart's image
BioAtla
Price$0.52
Change+$0.01 (+1.96%)
Volume$1.8K
Capitalization29.79M
HOOKIPA Pharma
Price$1.59
Change+$0.02 (+1.27%)
Volume$2.5K
Capitalization19.14M
BCAB vs HOOK Comparison Chart
Loading...
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCAB vs. HOOK commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a Hold and HOOK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (BCAB: $0.51 vs. HOOK: $1.57)
Brand notoriety: BCAB and HOOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 468% vs. HOOK: 23%
Market capitalization -- BCAB: $29.79M vs. HOOK: $19.14M
BCAB [@Biotechnology] is valued at $29.79M. HOOK’s [@Biotechnology] market capitalization is $19.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileHOOK’s FA Score has 1 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • HOOK’s FA Score: 1 green, 4 red.
According to our system of comparison, HOOK is a better buy in the long-term than BCAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 7 TA indicator(s) are bullish while HOOK’s TA Score has 5 bullish TA indicator(s).

  • BCAB’s TA Score: 7 bullish, 3 bearish.
  • HOOK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BCAB is a better buy in the short-term than HOOK.

Price Growth

BCAB (@Biotechnology) experienced а +30.77% price change this week, while HOOK (@Biotechnology) price change was +3.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.48%. For the same industry, the average monthly price growth was +5.47%, and the average quarterly price growth was +1.42%.

Reported Earning Dates

BCAB is expected to report earnings on Aug 07, 2025.

HOOK is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+8.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCAB($29.8M) has a higher market cap than HOOK($19.1M). BCAB YTD gains are higher at: -13.735 vs. HOOK (-21.891). HOOK has higher annual earnings (EBITDA): -40.85M vs. BCAB (-66.23M). HOOK has more cash in the bank: 39.7M vs. BCAB (32.4M). BCAB has less debt than HOOK: BCAB (554K) vs HOOK (875K). HOOK has higher revenues than BCAB: HOOK (43.9M) vs BCAB (11M).
BCABHOOKBCAB / HOOK
Capitalization29.8M19.1M156%
EBITDA-66.23M-40.85M162%
Gain YTD-13.735-21.89163%
P/E RatioN/AN/A-
Revenue11M43.9M25%
Total Cash32.4M39.7M82%
Total Debt554K875K63%
FUNDAMENTALS RATINGS
HOOK: Fundamental Ratings
HOOK
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCABHOOK
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 19 days ago
71%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELEV0.310.01
+3.73%
Elevation Oncology
MT30.620.04
+0.13%
ArcelorMittal
BKH58.38-0.09
-0.15%
Black Hills Corp
LXRX0.62N/A
-0.80%
Lexicon Pharmaceuticals
HOV87.96-2.32
-2.57%
Hovnanian Enterprises

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+24.69%
AXON - BCAB
41%
Loosely correlated
+1.09%
DNLI - BCAB
39%
Loosely correlated
+5.44%
NVO - BCAB
39%
Loosely correlated
+1.86%
VCYT - BCAB
38%
Loosely correlated
+0.49%
CRSP - BCAB
38%
Loosely correlated
+1.82%
More